Is severe rejection an indication for retransplantation?

Transplant Proc. 2000 Sep;32(6):1201. doi: 10.1016/s0041-1345(00)01184-2.

Authors

T Kato¹, M Berho, D Weppler, P Ruiz, A D Pinna, F A Khan, J R Nery, A G Tzakis

Affiliation

¹ Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101-5809, USA.

PMID: 10995907
DOI: 10.1016/s0041-1345(00)01184-2

No abstract available

MeSH terms

Drug Therapy, Combination
Graft Rejection / pathology*
Humans
Immunosuppressive Agents / therapeutic use*
Intestines / pathology
Intestines / transplantation*
Muromonab-CD3 / therapeutic use
Reoperation
Retrospective Studies
Survival Rate
Time Factors
Transplantation, Homologous / immunology*
Transplantation, Homologous / mortality
Transplantation, Homologous / pathology*
Viscera / transplantation

Substances

Immunosuppressive Agents
Muromonab-CD3